02.08.2010 • NewsBilfingerSiegfried

Siegfried Outsources Support Functions

Siegfried Holding signed a cooperation agreement with two companies concerning the supply of support functions. In the future, Bilfinger Berger Industrial Services will provide maintenance, part of the engineering and security services and run the Siegfried Hazmat Training Center. All issues concerning utility supply and waste disposal will be handled by IHKW Industrieheizkraftwerk Zofingen, a subsidiary of GWE Gesellschaft für wirtschaftliche Energieversorgung located in Freiburg, Germany.

The agreement with Bilfinger Berger commences on Aug. 1,  and that with IHKW on Sept. 1. In total, 56 Siegfried members of staff will change their employer. With the new employers Siegfried negotiated two years' job security and protection of vested rights for a period of three years for its former employees.

Company

Logo:

Siegfried

Untere Brühlstr. 4
4800 Zofingen
Switzerland

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.